Constellium Heads Into Q3 Print With Bears in Retreat

Constellium SE reports Q3 results on October 28 with short sellers meaningfully less convicted than they were a month ago, even as the stock itself has pulled back from recent highs.

The positioning shift is the clearest signal heading into the print. Short interest has fallen 16% over the past month to 4.25% of the free float, with a further 4.7% drop on October 26 alone. Borrow conditions confirm there is no squeeze pressure: availability is effectively unlimited, and the cost to borrow has halved over the past week to just 0.31%, its lowest reading in the recent history. Options tell a similar story. The put/call ratio at 0.41 is almost exactly in line with its 20-day average, a z-score of -0.42, suggesting neither bulls nor bears are loading up ahead of the announcement.

The analyst debate leans constructive but with trimmed ambitions. UBS and Deutsche Bank both reiterated Buy ratings in early October while cutting targets, UBS to $32 from $34, Deutsche Bank to $36 from $39, reflecting macro caution rather than a change of view on the company. Barclays initiated at Equal-Weight with a $28 target on October 14, adding a more cautious voice to the mix. The mean price target across the Street is $30, roughly 22% above the current price of $24.56. Bulls point to Constellium's earnings yield, which ranks in the 95th percentile of the ORTEX universe, and an EV/EBITDA of around 5.6x, a valuation that leaves room for re-rating if execution holds. Bears counter that targets have moved only one direction since July and the stock is down 5% on the week, underperforming most peers: Kaiser Aluminum fell harder at nearly 30% on the week, but Arconic and Ternium both shed around 7%, meaning CSTM's relative resilience is limited.

One ownership development warrants attention. Caisse des Depots (CDC), the French state investment arm, filed a Schedule 13D in May, placing it on the activist register with a 6.2% stake. A 13D signals more than passive ownership; it indicates an intent to engage with management. As always, stakes are as last disclosed around the 5% threshold, and a holder can drop below without filing again. BlackRock has been adding, reporting 9.4% of shares as of September 30, while American Century nearly doubled its position to just over 3% in the same period. The institutional base is growing, even as the stock has retreated from the upper $30s seen earlier in the year.

Wikipedia page views for Constellium are running at a z-score of 3.4 against their own 90-day history, an unusually elevated level of retail attention for this stock, though this reflects interest rather than any read on the underlying business.

The print will test whether Constellium's margin trajectory justifies the constructive analyst consensus at a stock price that has drifted well below where most targets were set.